European committee takes a second look at Alzheimer’s drug and now says it should be approved ...Middle East

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug. Biogen said Thursday that the drug, known in the U.S. as Leqembi, received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use as a treatment for early Alzheimer’s disease. The European Commission is now expected to make a marketing authorization decision in the next few months. The committee had said in July that concerns about the drug’s potential side effects outweigh the impact it has in slowing the fatal, mind-robbing disease. But Japanese drugmaker Eisai asked the committee to reconsider its decision. E

Read More Details
Finally We wish PressBee provided you with enough information of ( European committee takes a second look at Alzheimer’s drug and now says it should be approved )

Also on site :

• Miss Manners: His driving was terrifying. Was I wrong to ask him to slow down?
• The Implications of GLP-1s on Women’s Healthcare
• China, Kenya upgrade ties amid 'turbulent international situation